National Centre for Clinical Research on Emerging Drugs (NCCRED)
Clinical practice meets clinical research
.cropimg.width=700.crop=video.png "NCCRED Logo transparent NDARC Web banners")
The National Centre for Clinical Research on Emerging Drugs (NCCRED) brings researchers, practitioners and consumers together to create a robust evidence base for treatment and interventions for people who use methamphetamine and emerging other drugs of concern.
About this program
NCCRED applies its vision by:
- Increasing the range of evidence-based pharmacotherapies and other clinical interventions
- Enabling more proactive and informed health responses to emerging drugs of concern through national information sharing
- Translating and communicating evidence for AOD workers to deliver best-practice responses
Program activity
Program contacts:
Professor Nadine Ezard
Director, National Centre for Clinical Research on Emerging Drugs | Clinical Director, Alcohol and Drug Service St Vincent's Hospital Sydney Australia
E: n.ezard@unsw.edu.au
Jemma Hallen
Project Manager, National Centre for Clinical Research on Emerging Drugs
Key collaborators
- National Drug and Alcohol Research Centre
- National Centre for Education and Training on Addiction (NCETA), opens in a new window
- National Drug Research Institute | Curtin University, opens in a new window
- St Vincents Health Australia, opens in a new window
- Australian Government - Department of Health and Aged Care, opens in a new window
.cropimg.width=1170.crop=basic.jpg)
